945
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Cost-effectiveness of TAVR in the non-surgical population

&
Pages 575-579 | Accepted 31 Jan 2013, Published online: 12 Feb 2013
 

Transparency

Declaration of funding

This paper was not funded.

Declaration of financial/other relationships

MJR is a consultant for Medtronics and is a principal investigator for the CoreValve® US Pivotal Trial. MR has received grant support from Edwards Lifesciences, and is a conclustant for Medtronics.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.